Format
Items per page
Sort by

Send to:

Choose Destination

Search results

Items: 1 to 20 of 468

1.

Causal Assessment of Serum Urate Levels in Cardiometabolic Diseases Through a Mendelian Randomization Study.

Keenan T, Zhao W, Rasheed A, Ho WK, Malik R, Felix JF, Young R, Shah N, Samuel M, Sheikh N, Mucksavage ML, Shah O, Li J, Morley M, Laser A, Mallick NH, Zaman KS, Ishaq M, Rasheed SZ, Memon FU, Ahmed F, Hanif B, Lakhani MS, Fahim M, Ishaq M, Shardha NK, Ahmed N, Mahmood K, Iqbal W, Akhtar S, Raheel R, O'Donnell CJ, Hengstenberg C, März W, Kathiresan S, Samani N, Goel A, Hopewell JC, Chambers J, Cheng YC, Sharma P, Yang Q, Rosand J, Boncoraglio GB, Kazmi SU, Hakonarson H, Köttgen A, Kalogeropoulos A, Frossard P, Kamal A, Dichgans M, Cappola T, Reilly MP, Danesh J, Rader DJ, Voight BF, Saleheen D.

J Am Coll Cardiol. 2016 Feb 2;67(4):407-16. doi: 10.1016/j.jacc.2015.10.086.

PMID:
26821629
2.

Impact of Metformin on the Severity and Outcomes of Acute Ischemic Stroke in Patients with Type 2 Diabetes Mellitus.

Mima Y, Kuwashiro T, Yasaka M, Tsurusaki Y, Nakamura A, Wakugawa Y, Okada Y.

J Stroke Cerebrovasc Dis. 2016 Feb;25(2):436-46. doi: 10.1016/j.jstrokecerebrovasdis.2015.10.016. Epub 2015 Dec 22.

PMID:
26725260
3.

White matter changes after stroke in type 2 diabetic rats measured by diffusion magnetic resonance imaging.

Ding G, Chen J, Chopp M, Li L, Yan T, Davoodi-Bojd E, Li Q, Davarani SP, Jiang Q.

J Cereb Blood Flow Metab. 2015 Dec 18. pii: 0271678X15622464. [Epub ahead of print]

PMID:
26685128
4.

Epigenome-wide association study identifies TXNIP gene associated with type 2 diabetes mellitus and sustained hyperglycemia.

Soriano-Tárraga C, Jiménez-Conde J, Giralt-Steinhauer E, Mola-Caminal M, Vivanco-Hidalgo RM, Ois A, Rodríguez-Campello A, Cuadrado-Godia E, Sayols-Baixeras S, Elosua R, Roquer J; GENESTROKE Consortium.

Hum Mol Genet. 2015 Dec 7. pii: ddv493. [Epub ahead of print]

PMID:
26643952
5.

Provider costs for prevention and treatment of cardiovascular and related conditions in low- and middle-income countries: a systematic review.

Brouwer ED, Watkins D, Olson Z, Goett J, Nugent R, Levin C.

BMC Public Health. 2015 Nov 26;15(1):1183. doi: 10.1186/s12889-015-2538-z.

6.

A competing risk analysis of sequential complication development in Asian type 2 diabetes mellitus patients.

Cheng LJ, Chen JH, Lin MY, Chen LC, Lao CH, Luh H, Hwang SJ.

Sci Rep. 2015 Oct 28;5:15687. doi: 10.1038/srep15687.

7.

Effects on Clinical Outcomes of Adding Dipeptidyl Peptidase-4 Inhibitors Versus Sulfonylureas to Metformin Therapy in Patients With Type 2 Diabetes Mellitus.

Ou SM, Shih CJ, Chao PW, Chu H, Kuo SC, Lee YJ, Wang SJ, Yang CY, Lin CC, Chen TJ, Tarng DC, Li SY, Chen YT.

Ann Intern Med. 2015 Nov 3;163(9):663-72. doi: 10.7326/M15-0308. Epub 2015 Oct 13.

PMID:
26457538
8.

[Cerebral vascular lesions in diabetes mellitus: solved and unresolved questions].

Dedov II, Shestakova MV.

Zh Nevrol Psikhiatr Im S S Korsakova. 2015;115(8):79-82. Review. Russian.

PMID:
26451406
9.

Effects of Pioglitazone for Secondary Stroke Prevention in Patients with Impaired Glucose Tolerance and Newly Diagnosed Diabetes: The J-SPIRIT Study.

Tanaka R, Yamashiro K, Okuma Y, Shimura H, Nakamura S, Ueno Y, Tanaka Y, Miyamoto N, Tomizawa Y, Nakahara T, Furukawa Y, Watada H, Kawamori R, Hattori N, Urabe T.

J Atheroscler Thromb. 2015 Dec 1;22(12):1305-16. doi: 10.5551/jat.30007. Epub 2015 Aug 11.

10.

Intake of saturated and trans unsaturated fatty acids and risk of all cause mortality, cardiovascular disease, and type 2 diabetes: systematic review and meta-analysis of observational studies.

de Souza RJ, Mente A, Maroleanu A, Cozma AI, Ha V, Kishibe T, Uleryk E, Budylowski P, Schünemann H, Beyene J, Anand SS.

BMJ. 2015 Aug 11;351:h3978. doi: 10.1136/bmj.h3978. Review.

11.

Troponin and Cardiac Events in Stable Ischemic Heart Disease and Diabetes.

Everett BM, Brooks MM, Vlachos HE, Chaitman BR, Frye RL, Bhatt DL; BARI 2D Study Group.

N Engl J Med. 2015 Aug 13;373(7):610-20. doi: 10.1056/NEJMoa1415921.

PMID:
26267622
12.

Neurorestorative Therapy of Stroke in Type 2 Diabetes Mellitus Rats Treated With Human Umbilical Cord Blood Cells.

Yan T, Venkat P, Chopp M, Zacharek A, Ning R, Cui Y, Roberts C, Kuzmin-Nichols N, Sanberg CD, Chen J.

Stroke. 2015 Sep;46(9):2599-606. doi: 10.1161/STROKEAHA.115.009870. Epub 2015 Aug 4.

PMID:
26243222
13.

Role of apolipoprotein E in neurodegenerative diseases.

Giau VV, Bagyinszky E, An SS, Kim SY.

Neuropsychiatr Dis Treat. 2015 Jul 16;11:1723-37. doi: 10.2147/NDT.S84266. eCollection 2015. Review.

14.

Sitagliptin After Ischemic Stroke in Type 2 Diabetic Patients: A Nationwide Cohort Study.

Chen DY, Wang SH, Mao CT, Tsai ML, Lin YS, Su FC, Chou CC, Wen MS, Wang CC, Hsieh IC, Hung KC, Cherng WJ, Chen TH.

Medicine (Baltimore). 2015 Jul;94(28):e1128. doi: 10.1097/MD.0000000000001128.

15.

Biomarkers Associated with Ischemic Stroke in Diabetes Mellitus Patients.

Yang S, Zhao J, Chen Y, Lei M.

Cardiovasc Toxicol. 2015 Jul 15. [Epub ahead of print]

PMID:
26175178
16.
17.

Gene Variant and Level of IL-1β in Ischemic Stroke Patients With and Without Type 2 Diabetes Mellitus.

Chehaibi K, Hrira MY, Trabelsi I, Escolà-Gil JC, Slimane MN.

J Mol Neurosci. 2015 Nov;57(3):404-9. doi: 10.1007/s12031-015-0614-6. Epub 2015 Jul 9.

PMID:
26156202
18.
19.

Prediction, medical illness and the risk of pre-eclampsia.

Tranquilli AL.

Pregnancy Hypertens. 2014 Jul;4(3):245. doi: 10.1016/j.preghy.2014.04.017. Epub 2014 Jul 9.

PMID:
26104646
20.

Risk factor differences between type 2 diabetes patients with ischemic cerebrovascular versus coronary heart diseases at admission.

Yang Y, Huang B, Tan S, Chen H, Chen Y, Dang C, Liu G, Fan Y, Yu J, Zeng J.

J Diabetes Complications. 2015 Aug;29(6):783-7. doi: 10.1016/j.jdiacomp.2015.04.016. Epub 2015 Apr 28.

PMID:
26071381
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk